Biodesix, Inc.
Clinical trials sponsored by Biodesix, Inc., explained in plain language.
-
New blood test could spare thousands from unnecessary lung surgery
Diagnosis OngoingThis study is testing whether a blood test called Nodify XL2 can help doctors decide how to manage lung nodules that have a low to moderate chance of being cancer. About 2,000 adults with solid lung nodules between 8 and 30 mm are taking part. The goal is to see if using the test…
Sponsor: Biodesix, Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 18:51 UTC
-
Blood test may help doctors choose best lung cancer therapy
Knowledge-focused OngoingThis observational study tracks over 5,000 people with non-small cell lung cancer to see how doctors use the VeriStrat blood test when deciding on treatment. Researchers want to learn if the test results change what therapy patients receive and whether new experimental tests can …
Sponsor: Biodesix, Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:08 UTC